Back to top

Image: Bigstock

Canopy Growth (CGC) in Focus: Stock Moves 11.1% Higher

Read MoreHide Full Article

Canopy Growth Corporation (CGC - Free Report) was a big mover last session, as the company saw its shares rise more than 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up 37.4% in the past one-month time frame.

The move came after the company reported that it has received a license for producing and processing hemp from the New York State.

The company has seen its Zacks Consensus Estimate for the current quarter move higher over the past few weeks, suggesting that more solid trading could be ahead for Canopy Growth. So, make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Canopy Growth currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.  

A better-ranked stock in the Medical - Products industry is TG Therapeutics, Inc. (TGTX - Free Report) , which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is CGC going up? Or down? Predict to see what others think: Up or Down

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


TG Therapeutics, Inc. (TGTX) - free report >>

Canopy Growth Corporation (CGC) - free report >>

Published in